For Release 07:00, 26 September 2024
NetScientific
plc
("NetScientific" or the "Company")
Name change and AIM Rule 26
website
NetScientific Plc (AIM: NSCI), the
deep tech and life sciences VC investment group, is pleased to
announce that it has changed its name to "EMV Capital plc".
Regulatory information concerning the Company's name
change
The Company was issued by Companies
House with a change of name certificate on 25 September 2024 and
the name change from "NetScientific plc" to "EMV Capital plc"
became effective immediately upon such receipt. Similarly, the
Company's wholly owned venture capital and corporate finance firm,
EMV Capital Limited, has changed its name to EMV Capital Partners
Limited with immediate effect.
The Company confirms that its change
of name has been notified to the London Stock Exchange and trading
in the Company's shares under the new company name and new TIDM
code, "EMVC", is expected to commence at 8.00 a.m. on 26 September
2024. The Company's ISIN and SEDOL remain unchanged.
In conjunction with its name change,
the Company's website address will change to emvcapital.com. All
information required by Rule 26 of the AIM Rules for Companies will
be located on the "Investors" section of the website with effect
from 8.00 a.m. on 26 September 2024.
Shareholders rights are unaffected
by these changes and existing share certificates should be retained
and remain valid.
Background to the Company's name change and
rebranding
The rebranding marks the culmination
of NetScientific's strategic evolution, since acquiring EMV Capital
in 2020, to a fully integrated venture capital and corporate
finance business.
The Group has grown substantially in
both scale and scope since its inception. In 2019, the Group's
portfolio fair value stood at approximately £8 million. Today,
through its capital-efficient model and strategic value-creation
services, the Group has established itself as a key player in
venture capital, spanning deep tech, life sciences, and other
innovative sectors. The EMV Capital brand, used by the Group since
2020, is already highly regarded and well established in this
space, and as such the name change and rebranding across the Group
is a logical step towards unifying the Group's offerings to its
stakeholders.
EMV Capital plc now manages a
diversified portfolio of over 70 companies with estimated AUM
exceeding £100 million (as announced on 13 June 2024),
significantly expanding beyond its origins and is uniquely
positioned to leverage its expertise across fund management,
corporate finance, and portfolio growth services to deliver
positive returns for investors, even when market conditions remain
challenging.
As EMV Capital plc, the Group continues
its expansion beyond life sciences into deep tech, including
sectors such as sustainability, digital health, and advanced
materials. The Company's ability to provide fund management,
corporate finance, and syndication services across its portfolio
enables it to identify, nurture, and accelerate the growth of
early-stage companies. By offering hands-on support through each
growth phase, EMV Capital is committed to helping companies scale
while delivering meaningful societal impact.
With a goal to further grow Assets
Under Management, the Group aims to scale its capital-efficient
investment model, expand its fund management practice, and enhance
the value of its portfolio through targeted investments and
value-creation services.
Dr.
Ilian Iliev, CEO of EMV Capital plc, commented:
"Since acquiring EMV Capital in 2020, we have consolidated our
operations, significantly grown our portfolio, and expanded our
strategic focus. This new identity for our Group reflects our
business today-an agile, multi-sector venture capital firm
committed to delivering superior returns from innovative,
high-growth companies.
"With Assets Under Management having surpassed £100 million,
this milestone highlights our success in navigating a challenging
market and underscores our ambitious plans for the future. Our
continued focus on deep tech and life sciences, combined with our
value-creation approach, positions EMV Capital to be at the
forefront of driving the next wave of innovation and shareholder
value."
-Ends-
For
more information, please contact:
|
EMV
Capital plc
|
via Rosewood
|
Ilian Iliev, CEO
|
|
|
|
Panmure Liberum (UK) Limited (NOMAD and Broker)
|
+44 (0)20 7886 2500
|
Emma Earl / Will Goode / Freddy
Crossley / Mark Rogers (Corporate Finance)
|
|
Rupert Dearden (Corporate
Broking)
|
|
|
|
Rosewood (Financial
PR)
|
+44 (0)20 7653 8702
|
John West / Llewellyn Angus / Lily Pearce
|
|
About EMV Capital plc (EMVC)
EMV Capital plc, formerly known as
NetScientific plc, is a deep tech and life sciences venture capital
investment group with an international portfolio of high-growth
companies.
With a strategic focus on generating
superior returns for investors from the fast-growing sectors and
technologies that will define our future; EMV Capital invests in,
manages and strengthens early stage IP-rich companies.
EMV Capital holds both direct equity
stakes and carried interest in its portfolio companies, creating an
evergreen structure that supports extensive growth and value
creation. EMV Capital's investment thesis is realised through these
capital sources:
·
capital-efficient investments through Group
balance sheet;
·
fund management of the Evergreen EIS and Martlet
Capital Funds;
·
syndicated investments leveraging its network of
third-party investors.
EMV Capital's approach is
characterised by its proactive management style, aiming to advance
portfolio companies to critical value inflection points by actively
engaging with them. Companies are supported through Board
representation and the use of its Value Creation Services
practice.
Headquartered in London, with a
Cambridge presence and strong international links, EMV Capital is
quoted on the AIM market of the London Stock Exchange.
For more information, visit
www.emvcapital.com